Expression of the kynurenine pathway enzymes in human microglia and macrophages

Advances in Experimental Medicine and Biology

Volumn 527, Issue , 2003, Pages 105-112

  Guillemin, Gilles J ^a   Smith, Danielle G ^a   Smythe, George A ^b   Armati, Patricia J ^c   Brew, Bruce J ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYANTHRANILATE 3,4 DIOXYGENASE; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINASE; KYNURENINE; KYNURENINE 2 OXOGLUTARATE AMINOTRANSFERASE; KYNURENINE 3 MONOOXYGENASE; KYNURENINE PYRUVATE AMINOTRANSFERASE; PHOSPHORIBOSYLTRANSFERASE; QUINOLATE PHOSPHORIBOSYLTRANSFERASE; QUINOLINIC ACID; TRYPTOPHAN 2,3 DIOXYGENASE; UNCLASSIFIED DRUG;

ADULT; CELL STIMULATION; CONFERENCE PAPER; CONTROLLED STUDY; FETUS; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; MASS SPECTROMETRY; MICROGLIA; NERVE CELL CULTURE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 1042302739     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0135-0_12     Document Type: Conference Paper

References (33)

1. M.P. Heyes, K. Saito, S.P. Markey, Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid, Biochem. J. 283, 633-635 (1992).
2. B.J. Brew, L. Pemberton, L. Evans, M. Heyes, Quinolinic acid production by macrophages infected with demented and non-demented isolates of HIV, Clin. Neuropathol. 12, S1 (1993).
3. G.J. Guillemin, B.J. Brew, Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease (review), Redox Rep. in press, (2002).
4. P. Guidetti, P. Hemachandra Reddy, D.A., Tagle, R. Schwarcz, Early kynurenergic impairment in Huntington's Disease and in a transgenic animal model, Neurosci. Lett. 283, 233-235 (2000).
5. D.A. Bender, G.M. McCreanor, The preferred route of kynurenine metabolism in the rat, Biochim. Biophys. Acta 717, 56-60 (1982).
6. N.P. Botting, Chemistry and neurochemistry of the kynurenine pathway of tryptophan metabolism, Chem. Soc. Reviews 24, 401-412 (1995).
7. G. Curzon, Brain tryptophan. Normal and disturbed control, Adv. Exp. Med. Biol. 398, 27-34 (1996).
8. F. Moroni, Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites [In Process Citation], Eur. J. Pharmacol. 375, 87-100 (1999).
9. T.W. Stone, Neuropharmacology of quinolinic and kynurenic acids, Pharmacol. Rev. 45, 309-379 (1993).
10. I.P. Lapin, I.B. Prakhie, I.P. Kiseleva, Excitatory effects of kynurenine and its metabolites, amino acids and convulsants administered into brain ventricles: differences between rats and mice, J. Neural. Transm. 54, 229-238 (1982).
11. C.L. Eastman, Cytotoxicity of 3-hydroxykynurenine in a neuronal hybrid cell line, Brain Res. 495, 225-231 (1989).
12. G. Melillo, M.C. Bosco, T. Musso, L. Varesio, Immunobiology of picolinic acid, Adv. Exp. Med. Biol. 398, 135-141 (1996).
13. R. Schwarcz, W.O. Jr. Whetsell, R.M. Mangano, Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain, Science 219, 316-318 (1983).
14. M.P. Heyes, C.L. Achim, C.A. Wiley, E.O. Major, K. Saito, S.P. Markey, Human microglia convert L-tryptophan into the neurotoxin quinolinic acid, Biochem. J. 320: 595-597 (1996).
15. M.G. Espey, O.N. Chernyshev, J.J. Reinhard, M.A. Namboodiri, C.A. Colton, Activated human microglia produce the excitotoxin quinolinic acid, Neuroreport 8, 431-434 (1997).
16. G.J. Guillemin, S.J. Kerr, G.A. Smythe, D.G. Smith, V. Kapoor, P.J. Armati, J. Croitoru, B.J. Brew, Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection, J. Neurochem. 78, 1-13 (2001).
17. D. Alberati-Giani, P. Ricciardi-Castagnoli, C. Kohler, A.M. Cesura, Regulation of the kynurenine metabolic pathway by interferon-gamma in murine cloned macrophages and microglial cells, J. Neurochem. 66, 996-1004 (1996).
18. D. Alberati-Giani, A.M. Cesura, Expression of the kynurenine enzymes in macrophages and microglial cells: regulation by immune modulators, Amino Acids 14, 251-255 (1998).
19. M.P. Heyes, K. Saito, C.Y. Chen, M.G. Proescholdt, T.S. Jr. Nowak, J. Li, K.E. Beagles, M.A. Proescholdt, M.A. Zito, K. Kawai, S.P. Markey, Species heterogeneity between gerbils and rats: quinolinate production by microglia and astrocytes and accumulations in response to ischemic brain injury and systemic immune activation, J Neurochem 69, 1519-1529 (1997).
20. M.P. Heyes, C.Y. Chen, E.O. Major, K. Saito, Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types, Biochem. J. 326, 351-356 (1997).
21. L.A. Pemberton, S.J. Kerr, G. Smythe, B.J. Brew, Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alpha, and IFN-alpha, J. Interferon Cytokine Res. 17, 589-595 (1997).
22. C.U. Kloss, G.W. Kreutzberg, G. Raivich, Proliferation of ramified microglia on an astrocyte monolayer: characterization of stimulatory and inhibitory cytokines, J. Neurosci. Res. 49, 248-254 (1997).
23. D. Giulian, T.J. Baker, Characterization of ameboid microglia isolated from developing mammalian brain, Journal of Neuroscience 6, 2163-2178 (1986).
24. S.J. Kerr, P.J. Armati, L.A. Pemberton, G. Smythe, B. Tattam, B.J. Brew, Kynurenine pathway inhibition reduces toxicity of HIV-infected macrophages, Neurology 49, 1671-1681 (1997).
25. G. Guillemin, F.D. Boussin, J. Croitoru, M. Franck-Duchenne, R. Le Grand, F. Lazarini, D. Dormont, Obtention and characterization of primary astrocyte and microglial cultures from adult monkey brains, J. Neurosci. Res. 49, 576-591 (1997).
26. G.A. Smythe, S.J. Kerr, G.J. Guillemin, B.J. Brew, Quantification of picolinic acid using electron capture negative ion mass spectrometry, Anal. Biochem., submitted, (1998).
27. F. Villinger, D. Hunt, A. Mayne, M. Vuchetiv, H. Findley, and A.A. Ansari, Qualitative and quantitative studies of cytokines synthetized and secreted by non-human primate peripheral blood mononuclear cells, Cytokine 5, 169-179 (1993).
28. T.W. Stone, Endogenous neurotoxins from tryptophan, Toxicon 39, 61-73 (2001).
29. A.L. Cunningham, H. Naif, N. Saksena, G. Lynch, J. Chang, S. Li, R. Jozwiak, M. Alali, B. Wang, W. Fear, A. Sloane, L. Pemberton, B. Brew, HIV infection of macrophages and pathogenesis of AIDS dementia complex: interaction of the host cell and viral genotype, J. Leukoc. Biol. 62, 117-125 (1997).
30. F. Du, W. Schmidt, E. Okuno, R. Kido, C. Kohler, R. Schwarcz, Localization of kynurenine aminotransferase immunoreactivity in the rat hippocampus, J. Comp. Neural. 321, 477-487 (1992).
31. M. Tamburin, M. Mostardini, L. Benatti, Kynurenine aminotransferase I (KATI) isoform gene expression in the rat brain: an in situ hybridization study, Neuroreport 10, 61-65 (1999).
32. R. Kapoor, E. Okuno, R. Kido, V. Kapoor, Immuno-localization of kynurenine aminotransferase (KAT) in the rat medulla and spinal cord, Neuroreport 8, 3619-3623 (1997).
33. J. Urenjak, Obrenovitch, Neuroprotective potency of kynurenic acid against excitotoxicity, Ne T.P. uroreport 11, 1341-1344 (2000).